Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Location: Seattle WA, Stanford CA, Duarte CA, Minneapolis MN,
Sponsor: PeproMene Bio, Inc.

Sex: All

Age: 18+

Code: NCT05370430

Phase1, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Seattle WA, Portland OR, Eugene OR, Calgary,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase2, Recruiting

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

for
Squamous Non-small Cell Lung Cancer
Location: Seattle WA, Corvallis OR, St Louis MO, Austin TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07221474

Phase2, Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Seattle WA, San Antonio TX, Nashville TN, Pittsburgh PA,
Sponsor: Criterium, Inc.

Sex: All

Age: 18+

Code: NCT06992258

Phase2, Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Seattle WA, Omaha NE, Rochester MN, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876649

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Seattle WA, Omaha NE, Rochester MN, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876662

Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Seattle WA, Portland OR, Vancouver, Calgary,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Seattle WA, Portland OR, Los Angeles CA, La Jolla CA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase2, Recruiting

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

for
Non-Hodgkin's Lymphoma
Location: Seattle WA, Portland OR, Greenbrae CA, San Francisco CA,
Sponsor: Xcyte Therapies

Sex: All

Age: 18+

Code: NCT00081783

Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Seattle WA, Mount Vernon WA, Portland OR, Eugene OR,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

for
Multiple Myeloma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70

Code: NCT03570983

Phase2, Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

for
Carcinoma, Non-small-Cell Lung
Location: Seattle WA, Stanford CA, Orange CA, La Jolla CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05498428

Phase2, Recruiting

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Spokane WA, Dallas TX, Tyler TX, Ocoee FL
Sponsor: Corixa Corporation

Sex: All

Age: 18+

Code: NCT00062907

Phase1, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Seattle WA, Portland OR, Eugene OR, Calgary,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Seattle WA, Spokane WA, Sacramento CA, Palo Alto CA,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase2, Recruiting

Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial

for
Primary Spontaneous Pneumothorax
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT06411431

Recruiting

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for
Acute Leukemia
Location: Seattle WA, Portland OR, Vancouver, San Francisco CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2+

Code: NCT04811560

Phase1, Phase2, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Seattle WA, Las Vegas NV, Los Angeles CA, Cerritos CA,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase1, Phase2, Recruiting

Platelet-rich Fibrin and Grooving for Sagittal Split Osteotomy

for
Inferior Alveolar Nerve Injury, Nerve Injury,
Location: Seattle WA
Sponsor: Jesse Han

Sex: All

Age: 18+

Code: NCT04706182

Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Seattle WA, Edmonton, Salt Lake City UT, Los Angeles CA,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting